Abbott (ABT) said it now projects full-year 2026 adjusted EPS of $5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences. Abbott projects full-year 2026 comparable sales growth of 6.5% to 7.5%. The company projects second-quarter adjusted diluted earnings per share of $1.25 to $1.31.
Robert B. Ford, chairman and chief executive officer, said: "The acquisition of Exact Sciences adds another high-growth business to the Abbott portfolio, further strengthening our confidence in delivering accelerating growth as we move through the year."
On March 23, 2026, Abbott completed its acquisition of Exact Sciences.
In pre-market trading on NYSE, Abbott shares are down 4.3 percent to $97.18.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.